Sinopharm Group Co. Ltd. (SHTDF)
- Previous Close
0.0000 - Open
2.5000 - Bid 2.5000 x 40000
- Ask 3.2000 x 40000
- Day's Range
2.5000 - 2.5000 - 52 Week Range
1.9700 - 2.9500 - Volume
200 - Avg. Volume
3,954 - Market Cap (intraday)
8.371B - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
5.05 - EPS (TTM)
0.3900 - Earnings Date Oct 25, 2024 - Oct 29, 2024
- Forward Dividend & Yield 0.12 (6.23%)
- Ex-Dividend Date Jun 17, 2024
- 1y Target Est
--
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
www.sinopharmgroup.com.cn113,635
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHTDF
View MorePerformance Overview: SHTDF
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHTDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHTDF
View MoreValuation Measures
Market Cap
8.37B
Enterprise Value
16.52B
Trailing P/E
5.02
Forward P/E
5.89
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.07
Price/Book (mrq)
0.57
Enterprise Value/Revenue
0.20
Enterprise Value/EBITDA
4.58
Financial Highlights
Profitability and Income Statement
Profit Margin
1.47%
Return on Assets (ttm)
3.08%
Return on Equity (ttm)
11.90%
Revenue (ttm)
590.35B
Net Income Avi to Common (ttm)
8.65B
Diluted EPS (ttm)
0.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
43.33B
Total Debt/Equity (mrq)
82.54%
Levered Free Cash Flow (ttm)
8.82B
Company Insights: SHTDF
SHTDF does not have Company Insights